UFP Technologies
UFPT
292.87
-10.00
-3.30%
UFP Technologies
US · UFPT
#2677 by market cap
Listed 1970
292.87
-10.00
-3.30%
Live - 5344 symbols - heartbeat 510s ago
· 2026-10-08 07:17
Pre-market
289.00
-1.32%
After-hours
292.87
0.00%
- Market cap
- 2.27B
- P/E (TTM)i
- 31.66
- P/Bi
- 4.91
- EPSi
- 8.75
- Div yieldi
- 0.00%
- 52W posi
- 72%
Reader sentiment
Are you bullish or bearish on UFPT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 124.99% +0.19pp
- Institutions
- 337
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund114.55%
Hedge Fund5.35%
Individual/Insider3.42%
Public Company2.14%
Government Pension Fund1.51%
Family Office/Trust0.56%
Private Company0.45%
Insurance Company0.22%
Sovereign Wealth Fund0.13%
Top holders as of 2026-06-30
BlackRock
14.74% · 1.14M sh
Congress Asset Management Company, LLP
8.88% · 687.44K sh
Wasatch Advisors LP
8.82% · 683.26K sh
Neuberger Berman Investment Advisers LLC
6.93% · 537.04K sh
Vanguard Capital Management, LLC
4.97% · 384.62K sh
T. Rowe Price Group, Inc.
4.61% · 357.33K sh
Boston Trust Walden National Association
4.34% · 336.28K sh
State Street Global Advisors
4.04% · 312.81K sh
American Century Investment Management
3.61% · 279.98K sh
UBS Asset Management
3.46% · 268.10K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 26 buys · 23 sells
| Name | Role | Stake |
|---|---|---|
| R. Bailly | Chairman of the Board of Directors, President & CEO | 1.74% |
| Ronald Lataille | CFO, Senior VP & Treasurer | 0.60% |
| Mitchell Rock | President of MedTech | 0.35% |
| Marc Kozin | Independent Director | 0.26% |
| Thomas Oberdorf | Independent Director | 0.16% |
| Christopher Litterio | General Counsel, Secretary & Senior VP of Human Resources | 0.11% |
| Jason Holt | VP, GM of Advanced Components & Chief Commercial Officer of MedTech | 0.07% |
| Steven Cardin | VP & COO of MedTech | 0.05% |
| Cynthia Feldmann | Independent Director | 0.05% |
| Joseph Hassett | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-24 | Marc Kozin | Independent Director | Open Market Disposition | -7,000 | $303.97–305.07 |
| 2026-08-17 | Symeria Hudson | Independent Director | Open Market Disposition | -298 | $319.11 |
| 2026-08-13 | Symeria Hudson | Independent Director | Derivative Exercise and Sale | -1,196 | $167.98–324.58 |
| 2026-08-13 | Symeria Hudson | Independent Director | Open Market Disposition | -730 | $324.58 |
| 2026-08-13 | Symeria Hudson | Independent Director | Intent to Sell (Form 144) | -2,224 | -- |
| 2026-08-12 | Cynthia Feldmann | Independent Director | Open Market Disposition | -1,000 | $324.26 |
| 2026-08-09 | R. Bailly | Chairman of the Board of Directors, President & CEO | Open Market Disposition | -13,011 | $315.53–317.27 |
| 2026-08-06 | R. Bailly | Chairman of the Board of Directors, President & CEO | Open Market Disposition | -15,695 | $315.06–320.05 |
| 2026-08-05 | Christopher Litterio | General Counsel, Secretary & Senior VP of Human Resources | Intent to Sell (Form 144) | -1,000 | $322.00 |
| 2026-08-05 | Jason Holt | VP, GM of Advanced Components & Chief Commercial Officer of MedTech | Open Market Disposition | -1,100 | $317.00 |
| 2026-06-11 | Cynthia Feldmann | Independent Director | Derivative Exercise and Sale | -1,200 | $43.95–240.40 |
| 2026-06-04 | R. Bailly | Chairman of the Board of Directors, President & CEO | Sale to Issuer | -750 | $223.87 |
| 2026-06-04 | R. Bailly | Chairman of the Board of Directors, President & CEO | Other Acquisition | +1,787 | -- |
| 2026-06-03 | Ronald Lataille | CFO, Senior VP & Treasurer | Other Acquisition | +4,454 | -- |
| 2026-06-03 | Thomas Oberdorf | Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Daniel Croteau | Lead Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Marc Kozin | Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Mitchell Rock | President of MedTech | Other Acquisition | +2,895 | -- |
| 2026-06-03 | Cynthia Feldmann | Independent Director | Other Acquisition | +802 | -- |
| 2026-06-03 | Joseph Hassett | Independent Director | Other Acquisition | +802 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:17:36 · For reference only, not investment advice and not tailored to your situation.